Sort   by:  
 Page size 
UnknownTwice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma.
Not available
S-EPMC6055619 | biostudies-literature
UnknownLenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation.
Not available
S-EPMC5036168 | biostudies-literature
UnknownA phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma.
Not available
S-EPMC4123434 | biostudies-literature
UnknownMass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT).
Not available
S-EPMC8831597 | biostudies-literature
UnknownInternational Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.
Not available
S-EPMC3293742 | biostudies-literature
UnknownMonoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factors.
Not available
S-EPMC9324084 | biostudies-literature
Sort   by:  
 Page size